Litcius/Paper detail

Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial

Linyi Peng, Yuxue Nie, Jiaxin Zhou, Lijun Wu, Xiaomei Chen, Fang Wang, Jieqiong Li, Yu Peng, Hui Lu, Lidan Zhao, Mengtao Li, Yan Zhao, Xiaofeng Zeng, Yunyun Fei, Wen Zhang

2024Annals of the Rheumatic Diseases37 citationsDOI

Topics & Concepts

MedicineDiscontinuationIgG4-related diseaseInternal medicineAdverse effectRandomized controlled trialMaintenance therapyGastroenterologySurgeryDiseaseChemotherapyIgG4-Related and Inflammatory DiseasesNeuroendocrine Tumor Research AdvancesNasolacrimal Duct Obstruction Treatments
Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial | Litcius